Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Financials release
View:
Post by checkup on Mar 31, 2022 5:51pm

Financials release

https://www.medipharmlabs.com/news-post/medipharm-labs-reports-fourth-quarter-and-full-year-2021-results
Comment by mdjbrown on Mar 31, 2022 6:15pm
MediPharm Labs Reports Fourth Quarter and Full Year 2021 Results TORONTO, March 31, 2022 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three and twelve months ended December 31, 2021.  ...more  
Comment by checkup on Mar 31, 2022 6:22pm
54 Million net loss.....I don't know what to do with that......at the moment
Comment by corvette67 on Mar 31, 2022 6:25pm
It seems like in nine months they become Eve. GLTA
Comment by lscfa on Mar 31, 2022 8:06pm
Still writing down inventory in Q4. (The whole damn industry is sick).       Adjusted gross margin is still negative (WTF?)        Revenues flat again (see table, no growth) cowards will not give any guidance (at least Valens predicted cash breakeven by end of 2022) Share count climbing (see table)        ...more  
Comment by lscfa on Mar 31, 2022 10:52pm
Jan/feb/mar was completed today. Would it kill mgmt to ballpark a prelim revenue no. and disclose it now? WTF are these bozos hiding?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities